Emtricitabine And Tenofovir Disoproxil Fumarate
Product Images NDC 67296-1895

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 67296-1895). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Emtricitabine Structure (Emtricitabine Structure)

Chemical structure of Emtricitabine, an active ingredient in the Emtricitabine and Tenofovir Disoproxil Fumarate product by Redpharm Drug. The diagram shows the molecular framework with labeled atoms and bonds.*

FDA Label Image

Principal Display Panel (Container Label (30's count))

Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets containing 200 mg and 300 mg respectively. The label indicates a unit dose film-coated tablet format, a package of 30 tablets, and is manufactured for Laurus Generics Inc. The label includes storage instructions, dosage guidance, and a barcode.*

FDA Label Image

Tenofovir Disoproxil Fumarate Structure (Tenofovir Df Structure)

Chemical structure diagram of Emtricitabine and Tenofovir Disoproxil Fumarate active ingredient, depicting molecular bonds and functional groups of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.